Healthcare technology platform Kouper has officially emerged from stealth, securing $10m in investment from General Catalyst, 25Madison, and CVS Health Ventures.

This funding round also includes backing from several healthcare angel investors.

The newly acquired capital will be directed towards expanding the Kouper team and refining its product offerings.

Kouper aims to assist patients as they navigate transitions across various healthcare settings each year in the US.

The period following hospital discharge is widely recognised as a pivotal moment in a patient’s care journey.

Kouper addresses this critical phase by employing AI-driven infrastructure to enhance patient engagement and streamline appointment scheduling.

By integrating directly with health systems, Kouper harnesses real-time, contextual data throughout the entire care continuum.

Its AI-driven data platform consolidates disparate information to provide a comprehensive view of the patient journey, particularly following hospital-based events.

This approach aims to significantly enhance the effectiveness of transitions of care programmes.

By leveraging Kouper’s intelligent infrastructure, health systems and risk-bearing entities can improve patient access, coordination, and outcomes.

This can be achieved without the need for additional full-time staff or complex change management processes.

Kouper co-founder and CEO Salman Ali said: “The journey through the American health care system is fraught with challenges and can be particularly difficult when transitioning from the hospital to the home setting.

“A combination of our team’s lived experience and iteration with our incubation partner, 25m Health, laid the foundation for Kouper and our absolute focus on creating a personalised transition of care experience for every patient leaving the hospital.

“Our team and customer base are growing rapidly, and the validation we’ve received from our health system customers has been incredibly encouraging.”